Estrogen receptors in patients with malignant melanoma

Edward T. Creagan; James N. Ingle; John E. Woods; Douglas J. Pritchard; Nai‐Siang ‐S Jiang

doi:10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0

Estrogen receptors in patients with malignant melanoma

Edward T. Creagan, James N. Ingle, John E. Woods, Douglas J. Pritchard, Nai‐Siang ‐S Jiang

Medical Oncology

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran‐coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.

Original language	English (US)
Pages (from-to)	1785-1786
Number of pages	2
Journal	Cancer
Volume	46
Issue number	8
DOIs	https://doi.org/10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0
State	Published - Oct 15 1980

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0

Cite this

@article{6f9544b3e41442f19e1e3dc22c251be0,

title = "Estrogen receptors in patients with malignant melanoma",

abstract = "We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran‐coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.",

author = "Creagan, {Edward T.} and Ingle, {James N.} and Woods, {John E.} and Pritchard, {Douglas J.} and Jiang, {Nai‐Siang ‐S}",

year = "1980",

month = oct,

day = "15",

doi = "10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0",

language = "English (US)",

volume = "46",

pages = "1785--1786",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Estrogen receptors in patients with malignant melanoma

AU - Creagan, Edward T.

AU - Ingle, James N.

AU - Woods, John E.

AU - Pritchard, Douglas J.

AU - Jiang, Nai‐Siang ‐S

PY - 1980/10/15

Y1 - 1980/10/15

N2 - We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran‐coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.

AB - We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran‐coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.

UR - http://www.scopus.com/inward/record.url?scp=0018934646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018934646&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0

DO - 10.1002/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0

M3 - Article

C2 - 7427880

AN - SCOPUS:0018934646

SN - 0008-543X

VL - 46

SP - 1785

EP - 1786

JO - Cancer

JF - Cancer

IS - 8

ER -

Estrogen receptors in patients with malignant melanoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this